BridgeMD
New treatment option for Hypoxia
Official title Nasopharyngeal Airway Combined With Nasal High-flow Oxygen Therapy During Painless Gastroscopy in Obesity Patients
ClinicalTrials.gov ID: NCT06966934
What this study is testing
- What it's testing
- Gastroscopy is a commonly used, direct, and reliable method for screening and diagnosing digestive tract diseases. However, as an invasive examination, it can cause adverse reactions such as pain, nausea, vomiting, and choking cough in patients.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patients undergoing painless gastroscopy;
- Patients with an age greater than 18 years old;
- American Society of Anesthesiologists (ASA) physical status classification from Grade I to Grade III;
- Body Mass Index (BMI) greater than 28 kg/m²
You likely can't join if
- Patients with contraindications to endoscopic procedures or those who refuse sedation/anesthesia;
- Patients allergic to propofol, eggs, soybeans, milk, etc.;
- Patients with gastrointestinal tract obstruction and gastric emptying disorders;
- Patients with acute pharyngitis, tonsillitis, and upper respiratory tract infections;
- Patients in the acute exacerbation stage of respiratory diseases such as asthma, bronchitis, and chronic obstructive pulmonary disease (COPD);
- Patients with acute arrhythmia and those with severe heart diseases (congenital diseases, valvular diseases);
See the full eligibility criteria
- Patients undergoing painless gastroscopy;
- Patients with an age greater than 18 years old;
- American Society of Anesthesiologists (ASA) physical status classification from Grade I to Grade III;
- Body Mass Index (BMI) greater than 28 kg/m²
- Patients with contraindications to endoscopic procedures or those who refuse sedation/anesthesia;
- Patients allergic to propofol, eggs, soybeans, milk, etc.;
- Patients with gastrointestinal tract obstruction and gastric emptying disorders;
- Patients with acute pharyngitis, tonsillitis, and upper respiratory tract infections;
- Patients in the acute exacerbation stage of respiratory diseases such as asthma, bronchitis, and chronic obstructive pulmonary disease (COPD);
- Patients with acute arrhythmia and those with severe heart diseases (congenital diseases, valvular diseases);
- Patients with severe hepatic and renal insufficiency who require alternative treatment;
- Patients with severe mental disorders who need medications to control their symptoms;
- Patients with moderate or above anemia, abnormal coagulation function, and hematological diseases;
- Patients with nasal cavity lesions leading to severe nasal congestion;
- Pregnant and lactating patients.
The study team makes the final eligibility decision.
Where it's taking place
- Nanjing, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Nanjing, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.